Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

CPDA-1

Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) Solution

Standard Dose
Refer to label-specific dosage instructions.
Max Dose
See product label
Primary Use
Marketed solution containing ADENINE, ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE.
Summary

Product profile Marketed solution containing ADENINE, ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE.

Dose form and route SOLUTION · INTRAVENOUS

Structured Monograph

Clinical summary

Product profile Marketed solution containing ADENINE, ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE. Dose form and route SOLUTION · INTRAVENOUS

Monitoring

  • • Review the product-specific label before prescribing.

Interaction Notes

  • • Interaction data should be confirmed against the corresponding label.
CPDA-1 (Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) Solution) | Drug Monograph | MedicHelpline